Revvity introduces new workflow to accelerate newborn sequencing research

March 18, 2024
A “sample-to-answer” next generation newborn sequencing research workflow.

Revvity, Inc. announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagents and databases based on a lab’s needs.

The research-use only (RUO) offering from Revvity culminates in analysis and report, covering essential steps in the sequencing process. The workflow enables identification of variants in more than 350 genes, complemented by a large database of carefully pre-curated variants. The offering includes dried blood spot collection and processing devices, Chemagic kits and instruments for nucleic acid extraction, liquid handlers and reagents for library preparation, VICTOR2 D Instrument for sample quality control, and software capabilities. The workflow is compatible with the Element AVITI system and other NGS platforms. 

For research use only. Not for use in diagnostic procedures.

Revvity release